Rapid Mycoplasma Detection For Bioproduction Sample Testing

Regulatory guidance requires that all products derived from mammalian cell culture be tested for the presence of mycoplasmas, often referred to as the stealth invader or silent killer of high-value cell lines. Early and accurate detection of mycoplasma contamination aids in assuring compliance with regulatory guidance and helps protect against the spread of contamination into downstream processes and media. Explore the different steps in biopharmaceutical manufacturing where testing for mycoplasmas is typically performed, as well as how the MycoSEQ Plus kit can streamline workflow while enabling early detection of mycoplasma contamination. The kits flexible throughput supports fluctuating testing needs and enables reduced cost per reaction through batch-testing multiple samples.